ChemicalBook > CAS DataBase List > Panobacumab
Panobacumab
- Product Name
- Panobacumab
- CAS No.
- 885053-97-4
- Chemical Name
- Panobacumab
- Synonyms
- Panobacumab;Research Grade Panobacumab;Research Grade Panobacumab(DXX02101)
- CBNumber
- CB98080784
- Formula Weight
- 0
- MOL File
- Mol file
More
Less
Panobacumab Property
- form
- Liquid
- color
- Colorless to light yellow
More
Less
Panobacumab Chemical Properties,Usage,Production
Uses
Panobacumab (KBPA101) is a fully human IgM/κ monoclonal antibody generated by immortalizing human B lymphocytes against the LPS O polysaccharide of serotype O11 of P. aeruginosa[1].
in vivo
Panobacumab (KBPA101) (1-4 mg/kg; i.v.; once) protects mice from systemic infection with P. aeruginosa serotype O11 in a murine burn wound model[1].
Panobacumab (KBPA101) (0.005-0.4 mg/kg; i.v.; once) protects mice from local lung infection with P. aeruginosa serotype O11 in an acute lung infection model[1].
| Animal Model: | Female NMRI mice, murine burn wound model[1] |
| Dosage: | 1, 2, or 4 mg/kg |
| Administration: | Intravenous injection, single dose |
| Result: | Significantly reduced mortality compared to untreated control animals administered either immediately or 4 h postchallenge. |
| Animal Model: | BALB/c mice, acute lung infection model[1] |
| Dosage: | 0.005 to 0.4 mg/kg |
| Administration: | Intravenous injection, single dose |
| Result: | Led to rapid clearance of P. aeruginosa from the lung, completely cleared systemic P. aeruginosa from the spleen, whereas live bacteria were still present in untreated mice at 48 h postchallenge, showed milder macroscopic lung pathology at 6 and 24 h after infection. |
References
[1] Horn MP, et al. Preclinical in vitro and in vivo characterization of the fully human monoclonal IgM antibody KBPA101 specific for Pseudomonas aeruginosa serotype IATS-O11. Antimicrob Agents Chemother. 2010 Jun;54(6):2338-44. DOI:10.1128/AAC.01142-09
Panobacumab Preparation Products And Raw materials
Raw materials
Preparation Products
More
Less
Panobacumab Suppliers
- Tel
- 177-54423994 17754423994
- Fax
- QQ:2853530913
- 2853530910@QQ.com
- Country
- China
- ProdList
- 8000
- Advantage
- 62
- Tel
- 15817493340
- 981810490@qq.com
- Country
- China
- ProdList
- 1566
- Advantage
- 58
- Tel
- 027-65317797 15926423062
- Fax
- QQ:422450190
- 422450190@qq.com
- Country
- China
- ProdList
- 10308
- Advantage
- 58
- Tel
- 027-65279366 18108604356
- products@biolabreagent.com
- Country
- China
- ProdList
- 9868
- Advantage
- 58
- Tel
- 13720134139 086-15871494362 13720134139
- orders@jknbiochem.com
- Country
- China
- ProdList
- 6762
- Advantage
- 58
- Tel
- 021-65675885 18964387627
- customer_service@efebio.com
- Country
- China
- ProdList
- 11973
- Advantage
- 58
- Tel
- 0731-13823398 15111215862
- 313359644@qq.com
- Country
- China
- ProdList
- 4161
- Advantage
- 58
- Tel
- 0573-83568680 18057391398
- 3956524501@qq.com
- Country
- China
- ProdList
- 1442
- Advantage
- 58
- Tel
- 027-87008169 17762441161
- info@atagenix.com
- Country
- China
- ProdList
- 10001
- Advantage
- 58
- Tel
- 33175446423
- support@antibodysystem.com
- Country
- China
- ProdList
- 6739
- Advantage
- 58
885053-97-4, PanobacumabRelated Search:
Stamulumab
Sotrovimab
Rolinsatamab
Sintilimab
ITOLIZUMAB (monoclonal antybody)
Bococizumab
Research Grade Cantuzumab (DHD14203)
Emactuzumab
Intetumumab
Pritumumab